ImmuCell Corporation – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus for primary offering

Prospectus for primary offering

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Tomsche David Scott

Gathagan Bryan K.

Rosgen Steven T.

News Filter

Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024

Material Definitive Agreement, Termination of Material Definitive Agreement, Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Material Definitive Agreement, Financial Statements or Exhibits

Q3 2024 Highlights

Announces Preliminary, Unaudited Sales Results for Q3 2024

Proxies Filter

Definitive proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Notice of effectiveness